ArticleJAMA network open2021
Loving-Kindness Meditation vs Cognitive Processing Therapy for Posttraumatic Stress Disorder Among Veterans: A Randomized Clinical Trial.
Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01962714 (A Trial of Loving-Kindness Meditation and Cognitive Processing Therapy for PTSD), which is not on this map. Cited by 21 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Trial of Loving-Kindness Meditation and Cognitive Processing Therapy for PTSD
Who cites it
21 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Inclusion of sexual- and gender-minoritized individuals in randomized clinical trials of first-line treatments for posttraumatic stress disorder: A systematic literature review.Journal of traumatic stress · 2026Pooled it
- Loving-Kindness Meditation: Systematic Review of Neuroimaging Correlates in Long-Term Practitioners and Clinical Implications.Brain and behavior · 2025Pooled it
- A meta-analytic review of cognitive processing therapy with and without the written account.Journal of anxiety disorders · 2025Pooled it
- Effectiveness of Meditation Techniques in Treating Post-Traumatic Stress Disorder: A Systematic Review and Meta-Analysis.Medicina (Kaunas, Lithuania) · 2024Pooled it
- Trial
- Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder.European journal of psychotraumatology · 2025Trial
- Cognitive Processing Therapy for Posttraumatic Stress Disorder in Japan: A Randomized Clinical Trial.JAMA network open · 2025Trial
- The effects of a combination of cognitive interventions and loving-kindness meditations (C-METTA) on guilt, shame and PTSD symptoms: results from a pilot randomized controlled trial.European journal of psychotraumatology · 2024Trial
- Complementary and integrative health interventions for PTSD in Veterans and family members: A rapid systematic review and meta-analysis.Journal of military, veteran and family health · 2026Article
- Mindfulness Intervention for Navigating and Decreasing Stress (MINDS-V): Effectiveness of a Tailored Trauma-Informed Mental Health Intervention for Australian Veterans.Military medicine · 2026Article
- C-METTA reduces PTSD-related guilt and shame following interpersonal violence.European journal of psychotraumatology · 2025Article
- Investigating the Psychometric Properties and Measurement Invariance of the Forms of Self-Criticizing/Attacking and Self-Reassuring Scale in Veteran Men and Women.Journal of psychopathology and behavioral assessment · 2025Article
- Exploring dental anxiety as a mediator in the relationship between mindfulness or self-compassion and dental neglect.Heliyon · 2024Article
- Comprehensive Review of Chronic Stress Pathways and the Efficacy of Behavioral Stress Reduction Programs (BSRPs) in Managing Diseases.International journal of environmental research and public health · 2024Review
- Examining the Veterans Health Administration whole health model of care within the context of posttraumatic stress disorder.Psychological services · 2024Article
- Traumatized German soldiers with moral injury - value-based cognitive-behavioral group therapy to treat war-related shame.Frontiers in psychiatry · 2023Article
- Mindful self-compassion for veteran women with a history of military sexual trauma: feasibility, acceptability, potential benefits, and considerations.European journal of psychotraumatology · 2023Article
- Feasibility of Implementing a Mindfulness-Based Online Program for Latina Immigrants and the Staff that Work with Them.Mindfulness · 2023Article
- Randomized controlled trials of mind-body interventions for posttraumatic stress disorder: a systematic review.Frontiers in psychology · 2023Review
- Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
Abstract
Importance: Additional options are needed for treatment of posttraumatic stress disorder (PTSD) among veterans. Objective: To determine whether group loving-kindness meditation is noninferior to group cognitive processing therapy for treatment of PTSD. Design, Setting, and Participants: This randomized clinical noninferiority trial assessed PTSD and depression at baseline, posttreatment, and 3- and 6-month follow-up. Veterans were recruited from September 24, 2014, to February 5, 2018, from a large Veternas Affairs medical center in Seattle, Washington. A total of 184 veteran volunteers who met Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria for PTSD were randomized. Data collection was completed November 28, 2018, and data analyses were conducted from December 10, 2018, to November 5, 2019. Interventions: Each intervention comprised 12 weekly 90-minute group sessions. Loving-kindness meditation (n = 91) involves silent repetition of phrases intended to elicit feelings of kindness for oneself and others. Cognitive processing therapy (n = 93) combines cognitive restructuring with emotional processing of trauma-related content. Main Outcomes and Measures: Co-primary outcomes were change in PTSD and depression scores over 6-month follow-up, assessed by the Clinician-Administered PTSD Scale (CAPS-5; range, 0-80; higher is worse) and Patient-Reported Outcome Measurement Information System (PROMIS; reported as standardized T-score with mean [SD] of 50 [10] points; higher is worse) depression measures. Noninferiority margins were 5 points on the CAPS-5 and 4 points on the PROMIS depression measure. Results: Among the 184 veterans (mean [SD] age, 57.1 [13.1] years; 153 men [83.2%]; 107 White participants [58.2%]) included in the study, 91 (49.5%) were randomized to the loving-kindness group, and 93 (50.5%) were randomized to the cognitive processing group. The mean (SD) baseline CAPS-5 score was 35.5 (11.8) and mean (SD) PROMIS depression score was 60.9 (7.9). A total of 121 veterans (66%) completed 6-month follow-up. At 6 months posttreatment, mean CAPS-5 scores were 28.02 (95% CI, 24.72-31.32) for cognitive processing therapy and 25.92 (95% CI, 22.62-29.23) for loving-kindness meditation (difference, 2.09; 95% CI, -2.59 to 6.78), and mean PROMIS depression scores were 61.22 (95% CI, 59.21-63.23) for cognitive processing therapy and 58.88 (95% CI, 56.86-60.91) for loving-kindness meditation (difference, 2.34; 95% CI, -0.52 to 5.19). In superiority analyses, there were no significant between-group differences in CAPS-5 scores, whereas for PROMIS depression scores, greater reductions were found for loving-kindness meditation vs cognitive processing therapy (for patients attending ≥6 visits, ≥4-point improvement was noted in 24 [39.3%] veterans receiving loving-kindness meditation vs 9 (18.0%) receiving cognitive processing therapy; P = .03). Conclusions and Relevance: Among veterans with PTSD, loving-kindness meditation resulted in reductions in PTSD symptoms that were noninferior to group cognitive processing therapy. For both interventions, the magnitude of improvement in PTSD symptoms was modest. Change over time in depressive symptoms was greater for loving-kindness meditation than for cognitive processing therapy. Trial Registration: Clinicaltrials.gov Identifier: NCT01962714.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.